Results 21 to 30 of about 51,391 (176)

In vivo study of anticancer activity of ginsenoside Rh2-containing arginine-reduced graphene in a mouse model of breast cancer [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2022
Objective(s): This study aims to evaluate the in vivo anticancer activity of arginine-reduced graphene (Gr-Arg) and ginsenoside Rh2-containing arginine-reduced graphene (Gr-Arg-Rh2).
Shervindokht Farhangfar   +7 more
doaj   +1 more source

Ginsenoside Rh2 Ameliorates Neuropathic Pain by inhibition of the miRNA21-TLR8-mitogen-activated protein kinase axis

open access: yesMolecular Pain, 2022
Ginsenoside Rh2 is one of the major bioactive ginsenosides in Panax ginseng . Although Rh2 is known to enhance immune cells activity for treatment of cancer, its anti-inflammatory and neuroprotective effects have yet to be determined.
Yuan-Yuan Fu   +5 more
doaj   +1 more source

Ginsenoside Rh2 inhibits breast cancer cell growth viaERβ-TNFα pathway

open access: yesActa Biochimica et Biophysica Sinica, 2022
Ginsenoside Rh2 is one of rare panaxidiols extracted from Panax ginseng and a potential estrogen receptor ligand that exhibits moderate estrogenic activity.
Peng Kunjian   +11 more
doaj   +1 more source

Infrared and Raman Spectroscopy of the Dirhodium Tetraacetate Complexes Rh2(O2CCH3)4, Rh2(18O2CCH3)4, Rh2(O2CCD3)4 and Rh2(O2CCH3)4(H2O)2

open access: yesCroatica Chemica Acta, 1988
The infrared (3500-50 cm-I), and Raman (3550-30 cm-I) spectra of the dirhodium tetraacetate species Rh2(02CCHs)4, Rh2(IB02CCHs)4, Rh2(02CCDS)4, and Rh2(02CCHs)4(H20)2 have been recorded and the key bands assigned, The oxygen-18 and deuteration studies, in particular, assisted with ma king the important band assignments for the anhydrous complex, for ...
Clark, Robin J. H., Hempleman, Andrew J.
openaire   +3 more sources

Tumor cell membrane-camouflaged responsive nanoparticles enable MRI-guided immuno-chemodynamic therapy of orthotopic osteosarcoma

open access: yesBioactive Materials, 2022
Osteosarcoma is a refractory bone disease in young people that needs the updating and development of effective treatment. Although nanotechnology is widely applied in cancer therapy, poor targeting and inadequate efficiency hinder its development.
Liwen Fu   +4 more
doaj   +1 more source

Ginsenoside Rh2 inhibits thyroid cancer cell migration and proliferation via activation of miR-524-5p

open access: yesArchives of Medical Science, 2020
Introduction Thyroid cancer is an important disease that threatens the health of humans. Ginsenoside Rh2 is known as an anticancer molecule; however, its function in thyroid cancer cells has not been reported. In the present study, we identified that Rh2
Shan Jiang   +6 more
doaj   +1 more source

Synergistic Effect of Ginsenoside Rh2 Combines with Ionizing Radiation on CT26/luc Colon Carcinoma Cells and Tumor-Bearing Animal Model

open access: yesPharmaceuticals, 2023
Background: The local tumor control rate of colon cancer by radiotherapy is unsatisfactory due to recurrence and radioresistance. Ginsenoside Rh2 (Rh2), a panoxadiol saponin, possesses various antitumor effects.
Shan-Chih Lee   +7 more
doaj   +1 more source

AMP-activated protein kinase determines apoptotic sensitivity of cancer cells to ginsenoside-Rh2

open access: yesJournal of Ginseng Research, 2014
Ginseng saponins exert various important pharmacological effects with regard to the control of many diseases, including cancer. In this study, the anticancer effect of ginsenosides on human cancer cells was investigated and compared.
Min-Jung Kim   +6 more
doaj   +1 more source

Borylcyclopropanes: Synthetic Strategies and Applications

open access: yesAngewandte Chemie, EarlyView.
Borylcyclopropanes (cyclopropanes bearing a boron substituent) sit at the intersection of two privileged frameworks in synthesis. This review provides the first exhaustive survey of their chemistry, spanning metal–carbene, nucleophilic cyclization, radical, hydroboration, and C─H activation routes, and documenting applications in medicinal chemistry ...
Aiza A. Butt, Joseph M. Ready
wiley   +2 more sources

The Anti-Inflammatory Effect and Mucosal Barrier Protection of Clostridium butyricum RH2 in Ceftriaxone-Induced Intestinal Dysbacteriosis

open access: yesFrontiers in Cellular and Infection Microbiology, 2021
This study aimed at determining the beneficial effect of Clostridium butyricum (CB) RH2 on ceftriaxone-induced dysbacteriosis. To this purpose, BALB/c mice were exposed to ceftriaxone (400 mg/ml) or not (control) for 7 days, and administered a daily oral
Yuyuan Li   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy